Compare KRRO & PDEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRRO | PDEX |
|---|---|---|
| Founded | 2014 | 1978 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 196.4M | 194.1M |
| IPO Year | 2019 | 1995 |
| Metric | KRRO | PDEX |
|---|---|---|
| Price | $12.67 | $64.93 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $21.50 | N/A |
| AVG Volume (30 Days) | ★ 212.2K | 26.4K |
| Earning Date | 11-05-2026 | 10-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.31 |
| EPS | N/A | ★ 0.92 |
| Revenue | $6,392,000.00 | ★ $77,548,000.00 |
| Revenue This Year | N/A | $8.32 |
| Revenue Next Year | N/A | $4.76 |
| P/E Ratio | ★ N/A | $70.72 |
| Revenue Growth | ★ 181.46 | 16.45 |
| 52 Week Low | $5.20 | $28.81 |
| 52 Week High | $17.35 | $77.00 |
| Indicator | KRRO | PDEX |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 52.38 |
| Support Level | $11.81 | $56.50 |
| Resistance Level | $14.47 | $68.86 |
| Average True Range (ATR) | 1.45 | 3.90 |
| MACD | -0.22 | 0.67 |
| Stochastic Oscillator | 24.60 | 55.42 |
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability. The company operates and manages its business as one reportable segment and one operating segment, which is the business of discovering, developing and commercializing therapies derived from or incorporating its RNA-editing technology.
Pro-Dex Inc is engaged in the design, development, manufacture, sale and repair of handheld medical devices and accessories, with products including Powered Surgical Drivers, Precision Air Powered Motors and others, including autoclavable, battery-powered and electric multi-function surgical drivers and shavers used mainly in the orthopedic, thoracic and craniomaxillofacial markets, as well as providing engineering, quality, regulatory consulting, NRE and prototype services, and manufacturing and selling rotary air motors and precision machined parts and assemblies for the aerospace and defense industries, with the majority of revenue derived from designing, developing, manufacturing and repairing powered surgical instruments for medical device original equipment manufacturers.